tyrosine and Spinal Neoplasms

tyrosine has been researched along with Spinal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, J; Jiang, L; Liang, Y; Liu, P; Wang, H; Wang, S	1

Other Studies

1 other study(ies) available for tyrosine and Spinal Neoplasms

Article	Year
CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway. International journal of oncology, 2018, Volume: 53, Issue:4 Topics: Adult; Aged; Animals; Antineoplastic Agents; Carcinoma; Chemokine CX3CL1; CX3C Chemokine Receptor 1; ErbB Receptors; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Male; Mice, Inbred NOD; Mice, SCID; Middle Aged; Neoplasm Invasiveness; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Signal Transduction; Spinal Neoplasms; src-Family Kinases; Tyrosine; Xenograft Model Antitumor Assays	2018

Article

Year

CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway.

International journal of oncology, 2018, Volume: 53, Issue:4

Topics: Adult; Aged; Animals; Antineoplastic Agents; Carcinoma; Chemokine CX3CL1; CX3C Chemokine Receptor 1; ErbB Receptors; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Male; Mice, Inbred NOD; Mice, SCID; Middle Aged; Neoplasm Invasiveness; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Signal Transduction; Spinal Neoplasms; src-Family Kinases; Tyrosine; Xenograft Model Antitumor Assays

2018